In this direction, Duan et al reported an epigenetic-targeting treatment alternative for PCa using JMJD2 inhibitor to stabilize H3K9 methylation level, thus repressing AR-driven transcription [32]. The gene discussed is KDM4A; the disease is posterior cortical atrophy.